z-logo
Premium
Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis
Author(s) -
Khurana Arushi,
Dalland Joanna C.,
Young Jason R.,
Inwards David J.,
Paludo Jonas
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26233
Subject(s) - blastoid , mantle cell lymphoma , medicine , refractory (planetary science) , complete remission , lymphoma , oncology , chemotherapy , biology , astrobiology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom